financetom
Business
financetom
/
Business
/
Capri forecasts annual revenue below estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Capri forecasts annual revenue below estimates
Feb 5, 2025 4:18 AM

(Reuters) - Capri Holdings ( CPRI ) forecast annual revenue below estimates on Wednesday, as the Michael Kors owner grappled with slowing demand for luxury goods and persistent declines in the Americas and Asia.

The company expects annual net revenue of $4.4 billion, compared with analysts' estimates of $4.5 billion, according to data compiled by LSEG.

(Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Sriraj Kalluvila)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
KULR Technology Stock Is Rising Tuesday: What's Going On?
KULR Technology Stock Is Rising Tuesday: What's Going On?
Jan 14, 2025
KULR Technology Group Inc ( KULR ) shares are trading higher Tuesday after the company announced the signing of a multi-million-dollar licensing agreement with a new technology partner. What Happened: KULR Technology ( KULR ) said it signed a licensing agreement to enable advanced carbon fiber cathode applications for nuclear reactor systems in Japan. The carbon fiber-based thermal interface materials...
Medtronic Says Centers for Medicare & Medicaid Services Opening National Coverage Analysis on Renal Denervation
Medtronic Says Centers for Medicare & Medicaid Services Opening National Coverage Analysis on Renal Denervation
Jan 14, 2025
10:11 AM EST, 01/14/2025 (MT Newswires) -- Medtronic ( MDT ) said late Monday that the US Centers for Medicare & Medicaid Services, or CMS, is introducing a national coverage analysis on renal denervation. The CMS will evaluate and develop a national Medicare coverage policy for renal denervation methods for patients with hypertension, the company added. The agency initiated this...
Haemonetics Completes $67.8 Million Sale of Whole Blood Assets to GVS
Haemonetics Completes $67.8 Million Sale of Whole Blood Assets to GVS
Jan 14, 2025
10:11 AM EST, 01/14/2025 (MT Newswires) -- Haemonetics ( HAE ) said Tuesday it has completed the sale of its whole blood assets to GVS for $67.8 million. The transaction includes an upfront payment of $45.3 million, with potential additional earn-outs of up to $22.5 million over four years. The sale covers Haemonetics' ( HAE ) entire portfolio of proprietary...
Illumina Reports Preliminary Q4, 2024 Non-GAAP Earnings, Revenue
Illumina Reports Preliminary Q4, 2024 Non-GAAP Earnings, Revenue
Jan 14, 2025
10:09 AM EST, 01/14/2025 (MT Newswires) -- Illumina ( ILMN ) said Tuesday in a preliminary report it expects Q4 non-GAAP earnings of $0.91 to $0.93 per diluted share. Analysts polled by FactSet expect $0.91. The company will report its earnings Feb. 6 after the market close. Revenue for the quarter is expected to be $1.10 billion Analysts surveyed by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved